AstraZeneca Pharma India Limited — Others, 14-08-2025: Shareholders meeting

AstraZeneca Pharma India's 46th Annual General Meeting has concluded with significant approvals. Shareholders adopted the financial statements for the year ended March 31, 2025, and approved a dividend of Rs. 32 per equity share. Key appointments include Ms. Hooi Bien Chuah being re-appointed as a Director, and Mr. Praveen Rao Akkinepally appointed as the Managing Director for three years, effective July 1, 2025. The company also appointed M/s. Makarand M. Joshi & Co. as secretarial auditors for five years and ratified the cost auditor's remuneration. This reflects continuity in governance and a direct return for shareholders.